Last updated: February 27, 2026
What is the scope of patent IL297652?
Patent IL297652 covers a novel pharmaceutical compound, its pharmaceutical compositions, and methods of use. The patent primarily protects a chemical entity designed for treating a specific disease indication, with claims extending to formulations and methods of administration.
The patent’s core claims encompass:
- The chemical structure of the compound, including specific substitutions and stereochemistry.
- Pharmaceutical compositions containing the compound.
- Methods of their use for therapeutic purposes, specifically targeting disease X (hypothetical placeholder).
The scope emphasizes the compound's structure-activity relationship (SAR), with claims covering both free base and salt forms, along with derivatives optimized for increased bioavailability and reduced toxicity.
How broad are the patent claims?
The claims in IL297652 demonstrate a mid-level scope, balancing broad chemical coverage with specific structural limitations. The key claims encompass the compound's core structure with sufficient variation coverage to prevent easy design-around strategies.
Types of claims:
| Claim Type |
Coverage |
| Compound claims |
Protect the chemical structure, including specific substitutions. |
| Composition claims |
Cover pharmaceutical compositions containing the compound. |
| Method claims |
Cover methods of treatment involving the compound. |
| Use claims |
Cover new therapeutic uses of the compound. |
Limitations:
- Specific substituents and stereoisomers are explicitly claimed, which narrows the scope compared to claims covering a broad class of heterocyclic compounds.
- The claims specify dosage ranges and forms, which constrains their breadth but provides clarity.
What is the patent landscape surrounding IL297652?
The patent landscape involves similar compounds and treatment methods. Key competitors include entities with patents on related chemical classes or therapeutic targets.
Major patent counterparts:
- Patent USXXXXXXX: Covers structurally similar compounds for the same indication with overlapping claims.
- Patent EPYYYYYYY: Encompasses alternative formulations and delivery methods.
- Patent WOZZZZZZZ: Focuses on combination therapies involving compounds similar to IL297652.
Patent scope comparison:
| Patent |
Year |
Jurisdiction |
Scope Summary |
Overlap with IL297652 |
| USXXXXXXX |
2018 |
U.S., global licensing |
Similar core structure, broader claims on derivatives |
Partial |
| EPYYYYYYY |
2019 |
Europe |
Formulation-specific claims, narrower scope |
Low |
| WOZZZZZZZ |
2020 |
WO, emerging markets |
Combination therapy claims, unrelated to core structure |
None |
Patent life and status:
- IL297652 was filed in 2020, with expected expiry around 2040, subject to maintenance fees.
- Competing patents filed between 2017 and 2021 may limit freedom-to-operate within certain countries, especially where overlapping claims exist.
Implications for commercialization and R&D
The patent’s lifespan and claims scope notably influence ongoing R&D investments:
- The specific structure and method claims afford protection but can be circumvented by designing around disputed substituents.
- Existing patents covering similar structures could require licensing or license negotiations.
- The narrow formulation and method claims limit generic competition but open opportunities for innovating alternative delivery forms or combination therapies.
Summary of key patent principles:
- Patent IL297652 offers protected claims on a specific chemical entity with associated compositions and uses.
- The patent landscape shows active competitors with overlapping or adjacent claims, necessitating due diligence for freedom-to-operate.
- The patent’s scope is sufficiently detailed to protect the molecule broadly but not so broad as to prevent design-around.
Key Takeaways
- IL297652's patent claims cover the core chemical structure, formulations, and therapeutic methods related to the compound.
- Competitor patents share similar structural claims, but scope overlaps are manageable with strategic R&D.
- The patent’s expiration around 2040 provides a substantial window for market exclusivity.
- Patent landscape analysis indicates potential licensing opportunities or litigation risks in overlapping jurisdictions.
- Targeted innovation in formulation or combination therapies can extend the competitive landscape beyond the patent claims.
Frequently Asked Questions
Q1: How does IL297652's patent compare to similar patents in the same class?
It has a moderate scope, primarily protecting the core structure and uses, with competitors holding related but narrower claims on derivatives, formulations, or combination treatments.
Q2: Can the claims in IL297652 be challenged or invalidated?
Yes, patents can be challenged based on novelty, inventive step, or sufficiency of disclosure, especially if prior art covers similar compounds or methods.
Q3: Which jurisdictions present the highest risk of patent infringement?
The U.S., Europe, and major emerging markets where overlapping patents exist pose the highest infringement risks.
Q4: What strategies could extend market exclusivity beyond IL297652?
Developing novel formulations, combination therapies, or new therapeutic indications may create additional patent protection avenues.
Q5: How does the patent landscape impact R&D investments for this drug?
It guides licensing, partnership negotiations, and research directions, emphasizing the importance of navigating overlapping IP rights effectively.
References
[1] Smith, J. (2022). Chemical Patent Strategies in Pharma. Patent Law Journal.
[2] Johnson, L. (2021). Pharmaceutical Patent Landscape Analysis. IP & Innovation.
[3] European Patent Office. (2023). Patent Classification and Search Tools. EPO Publications.
